Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
116,964,738
-
Total 13F shares
-
51,568,692
-
Share change
-
-3,717,047
-
Total reported value
-
$84,529,392
-
Put/Call ratio
-
41%
-
Price per share
-
$1.64
-
Number of holders
-
111
-
Value change
-
-$2,975,455
-
Number of buys
-
54
-
Number of sells
-
47
Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q3 2025
As of 30 Sep 2025,
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,568,692 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, Kohlberg Kravis Roberts & Co. L.P., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, CM Management, LLC, C WorldWide Group Holding A/S, PANAGORA ASSET MANAGEMENT INC, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This page lists
111
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.